Catherine’s research centers on developing drugs and gene therapies for rare disease, with a focus on retinal gene therapy to improve vision in peroxisome disorders (PBD-ZSD). She has extensive experience forming and maintaining academic and industrial collaborations, coordinating multiple project arms, directly supervising and training students/employees, and fostering relationships with patient networks.